ASSESSING THE PUBLIC HEALTH IMPACT OF THE ADJUVANTED RESPIRATORY SYNCYTIAL VIRUS PREFUSION F PROTEIN VACCINE AMONG OLDER ADULTS IN THE UNITED STATES (US)

被引:0
|
作者
Molnar, D. [1 ]
La, E. M. [2 ]
Verelst, F. [1 ]
Curran, D. [1 ]
Poston, S. [2 ]
Van Bellinghen, L. A. [3 ]
Graham, J.
机构
[1] GSK, Wavre, WBR, Belgium
[2] GSK, Philadelphia, PA USA
[3] CHESS Hlth, Bonheiden, Belgium
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
EPH45
引用
收藏
页码:S172 / S172
页数:1
相关论文
共 50 条
  • [41] THE POTENTIAL BENEFIT OF RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINATION IN OLDER ADULTS: A COMPARISON OF THE UNITED STATES (US) AND UNITED KINGDOM (UK)
    Fust, K.
    Kohli, M.
    Panozzo, C. A.
    Weinstein, M. C.
    Buck, P.
    Gaswalla, P.
    VALUE IN HEALTH, 2022, 25 (12) : S121 - S121
  • [42] Respiratory syncytial virus knowledge, attitudes, and perceptions among adults in the United States
    La, Elizabeth M.
    Bunniran, Su
    Garbinsky, Diana
    Reynolds, Maria
    Schwab, Phil
    Poston, Sara
    Harrington, Lauriane
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01)
  • [43] Annual public health and economic burden of medically attended respiratory syncytial virus illnesses among US adults
    Averin, Ahuva
    Sato, Reiko
    Begier, Elizabeth
    Gessner, Bradford D.
    Snow, Vincenza
    Cane, Alejandro
    Quinn, Erin
    Atwood, Mark
    Kijauskaite, Goda
    Weycker, Derek
    VACCINE, 2024, 42 (26)
  • [44] The Public Health Impact of Vaccination with the Adjuvanted RSVPreF3 Vaccine in Irish Older Adults
    O'Kane, John
    Lucey, Des
    Zarkadoulas, Eleftherios
    IRISH JOURNAL OF MEDICAL SCIENCE, 2024, 193 : S234 - S234
  • [45] Hospitalizations for Respiratory Syncytial Virus Among Adults in the United States, 1997-2012
    Pastula, Susan T.
    Hackett, Judith
    Coalson, Jenna
    Jiang, Xiaohui
    Villafana, Tonya
    Ambrose, Christopher
    Fryzek, Jon
    OPEN FORUM INFECTIOUS DISEASES, 2017, 4 (01):
  • [46] Late Breaking Abstract - Efficacy of a respiratory syncytial virus (RSV) prefusion F protein vaccine (RSVPreF3 OA) in older adults with co-existing cardiorespiratory conditions
    Papi, Alberto
    Feldman, Robert G.
    Antonelli-Incalzi, Raffaele
    Steenackers, Katie
    Lee, Dong-Gun
    Ison, Michael G.
    Fissette, Laurence
    David, Marie-Pierre
    Marechal, Celine
    Van der Wielen, Marie
    Kostanyan, Lusine
    Hulstrom, Veronica
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [47] BUDGET IMPACT ANALYSIS OF RSVPREF VACCINE FOR PREVENTION OF RESPIRATORY SYNCYTIAL VIRUS (RSV) DISEASE AMONG OLDER ADULTS IN ARGENTINA
    Ares, Rey L.
    Averin, A.
    Zuccarino, N. S.
    Atwood, M.
    Vega, C.
    Sato, R.
    VALUE IN HEALTH, 2024, 27 (12) : S108 - S108
  • [48] Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F (RSVPreF3) Candidate Vaccine in Older Adults: Phase 1/2 Randomized Clinical Trial
    Leroux-Roels, Isabel
    Davis, Matthew G.
    Steenackers, Katie
    Essink, Brandon
    Vandermeulen, Corinne
    Fogarty, Charles
    Andrews, Charles P.
    Kerwin, Edward
    David, Marie Pierre
    Fissette, Laurence
    Vanden Abeele, Carline
    Collete, Delphine
    de Heusch, Magali
    Salaun, Bruno
    De Schrevel, Nathalie
    Koch, Juliane
    Verheust, Celine
    Dezutter, Nancy
    Struyf, Frank
    Mesaros, Narcisa
    Tica, Jelena
    Hulstrom, Veronica
    JOURNAL OF INFECTIOUS DISEASES, 2023, 227 (06): : 761 - 772
  • [49] Clinical and economic outcomes associated with respiratory syncytial virus vaccination in older adults in the United States
    Herring, William L.
    Zhang, Yuanhui
    Shinde, Vivek
    Stoddard, Jeffrey
    Talbird, Sandra E.
    Rosen, Brian
    VACCINE, 2022, 40 (03) : 483 - 493
  • [50] The epidemiology of medically attended respiratory syncytial virus in older adults in the United States: A systematic review
    Colosia, Ann D.
    Yang, Jin
    Hillson, Eric
    Mauskopf, Josephine
    Copley-Merriman, Catherine
    Shinde, Vivek
    Stoddard, Jeffrey
    PLOS ONE, 2017, 12 (08):